P030004S017

None

FDA Premarket Approval P030004 S017

This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.

Pre-market Approval Supplement Details

DeviceP030004S017
Classification NameNone
Applicant
PMAP030004
SupplementS017

Supplemental Filings

Supplement NumberDateSupplement Type
P030004Original Filing
S024 2020-06-02 30-day Notice
S023 2020-01-28 30-day Notice
S022 2019-11-21 30-day Notice
S021 2019-08-21 Normal 180 Day Track No User Fee
S020 2019-06-26 30-day Notice
S019 2019-06-06 30-day Notice
S018 2019-05-31 30-day Notice
S017
S016 2018-11-29 30-day Notice
S015 2018-05-08 30-day Notice
S014 2018-01-09 30-day Notice
S013 2017-09-21 30-day Notice
S012 2016-12-27 30-day Notice
S011 2016-06-22 Real-time Process
S010 2016-03-03 30-day Notice
S009 2015-11-18 30-day Notice
S008 2013-09-09 30-day Notice
S007 2013-06-17 30-day Notice
S006 2013-04-22 Normal 180 Day Track
S005 2012-01-26 Special (immediate Track)
S004
S003 2007-09-24 Special (immediate Track)
S002 2006-05-19 Normal 180 Day Track No User Fee
S001 2006-05-25 30-day Notice

NIH GUDID Devices

Device IDPMASupp
00847536006188 P030004 000
00847536006171 P030004 000
00847536006041 P030004 006
00847536006010 P030004 006
00836462002487 P030004 006
00836462002463 P030004 006
00836462005051 P030004 008
00836462005044 P030004 008

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.